HRP20090147T3 - Farmaceutski pripravak koji sadržava derivat pirimidin-a-ona obložen s enteričkim polimerom - Google Patents

Farmaceutski pripravak koji sadržava derivat pirimidin-a-ona obložen s enteričkim polimerom

Info

Publication number
HRP20090147T3
HRP20090147T3 HR20090147T HRP20090147T HRP20090147T3 HR P20090147 T3 HRP20090147 T3 HR P20090147T3 HR 20090147 T HR20090147 T HR 20090147T HR P20090147 T HRP20090147 T HR P20090147T HR P20090147 T3 HRP20090147 T3 HR P20090147T3
Authority
HR
Croatia
Prior art keywords
pyrimidine
polymer
enterical
pharmaceutical preparation
preparation containing
Prior art date
Application number
HR20090147T
Other languages
English (en)
Croatian (hr)
Inventor
Marinus J. Van Schie Dirk
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HRP20090147T3 publication Critical patent/HRP20090147T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20090147T 2003-09-02 2004-08-31 Farmaceutski pripravak koji sadržava derivat pirimidin-a-ona obložen s enteričkim polimerom HRP20090147T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320522.6A GB0320522D0 (en) 2003-09-02 2003-09-02 Formulation
PCT/EP2004/009726 WO2005021002A1 (en) 2003-09-02 2004-08-31 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer

Publications (1)

Publication Number Publication Date
HRP20090147T3 true HRP20090147T3 (hr) 2009-04-30

Family

ID=28686767

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090147T HRP20090147T3 (hr) 2003-09-02 2004-08-31 Farmaceutski pripravak koji sadržava derivat pirimidin-a-ona obložen s enteričkim polimerom

Country Status (30)

Country Link
US (2) US20060287346A1 (is)
EP (1) EP1663243B1 (is)
JP (1) JP4892346B2 (is)
KR (1) KR101115984B1 (is)
CN (2) CN1874778B (is)
AR (1) AR045547A1 (is)
AT (1) ATE422889T1 (is)
AU (1) AU2004268376B2 (is)
BR (1) BRPI0414038A (is)
CA (1) CA2537178C (is)
CY (1) CY1108953T1 (is)
DE (1) DE602004019547D1 (is)
DK (1) DK1663243T3 (is)
ES (1) ES2319124T3 (is)
GB (1) GB0320522D0 (is)
HR (1) HRP20090147T3 (is)
IL (1) IL173910A (is)
IS (1) IS2677B (is)
MA (1) MA28033A1 (is)
MX (1) MXPA06002436A (is)
MY (1) MY139165A (is)
NO (1) NO333744B1 (is)
NZ (1) NZ545453A (is)
PL (1) PL1663243T3 (is)
PT (1) PT1663243E (is)
RU (1) RU2359660C2 (is)
SI (1) SI1663243T1 (is)
TW (1) TWI343257B (is)
WO (1) WO2005021002A1 (is)
ZA (1) ZA200601599B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
KR101730290B1 (ko) 2007-05-11 2017-04-25 토마스 제퍼슨 유니버시티 신경변성 질환 및 장애의 치료 및 예방 방법
CN101687009A (zh) 2007-05-11 2010-03-31 宾夕法尼亚大学理事会 治疗皮肤溃疡的方法
AU2010239080B2 (en) 2009-04-24 2014-08-28 Iceutica Pty Ltd A novel formulation of diclofenac
ES2847883T3 (es) 2010-12-17 2021-08-04 Glaxo Group Ltd Uso de inhibidores de LP-PLA2 en el tratamiento y prevención de enfermedades oculares
US9173884B2 (en) 2011-11-30 2015-11-03 Trustees Of Boston College Inhibitors of phosphodiesterase 11 (PDE11)
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
AR101261A1 (es) 2014-07-22 2016-12-07 Glaxosmithkline Ip Dev Ltd Compuesto de tetrahidropirrolo[1,2:3,4]imidazo[1,2-c]pirimidin-1(6h)-ona y composición farmacéutica que lo comprende

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619570C1 (en) 1986-06-11 1987-10-29 Kneipp Werke Kneipp Mittel Zen Coated garlic tablet
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
TW209174B (is) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
JP2917799B2 (ja) * 1994-03-11 1999-07-12 田辺製薬株式会社 消化管内適所放出型製剤
JP3185206B2 (ja) * 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
IL127378A (en) * 1996-06-06 2003-07-31 Bifodan As Enteric coating for an oral preparation
US6709678B2 (en) * 1996-08-15 2004-03-23 Losan Pharma Gmbh Easy to swallow oral medicament composition
US6296876B1 (en) * 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
KR100554924B1 (ko) * 1998-05-18 2006-03-03 다케다 야쿠힌 고교 가부시키가이샤 구강내 붕괴 정제
CZ20011629A3 (cs) 1998-11-12 2001-12-12 Smithkline Beecham Plc Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
US6268385B1 (en) * 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
DK1263740T3 (da) * 2000-02-16 2006-11-13 Smithkline Beecham Plc Pyrimidin-4-on-derivat som LDL-PLA2-inhibitor
AUPQ672800A0 (en) * 2000-04-06 2000-05-04 Natraherbal Pty Ltd Garlic supplement for deodoriser
KR100786927B1 (ko) * 2000-06-28 2007-12-17 스미스클라인비이참피이엘시이 습식 분쇄방법
PT1405621E (pt) 2001-06-20 2011-05-31 Takeda Pharmaceutical Processo de prepara??o de comprimidos
JP5138856B2 (ja) * 2001-06-20 2013-02-06 武田薬品工業株式会社 錠剤の製造方法
RU2203671C1 (ru) * 2002-03-25 2003-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Противовирусный лекарственный препарат для перорального применения
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation

Also Published As

Publication number Publication date
BRPI0414038A (pt) 2006-10-24
AR045547A1 (es) 2005-11-02
US20060287346A1 (en) 2006-12-21
SI1663243T1 (sl) 2009-06-30
DK1663243T3 (da) 2009-05-04
EP1663243A1 (en) 2006-06-07
TW200517113A (en) 2005-06-01
CN102204891A (zh) 2011-10-05
PL1663243T3 (pl) 2009-07-31
ZA200601599B (en) 2007-05-30
IS8366A (is) 2006-03-20
CA2537178C (en) 2013-03-19
RU2006110546A (ru) 2006-08-10
CN1874778B (zh) 2011-06-22
ATE422889T1 (de) 2009-03-15
CA2537178A1 (en) 2005-03-10
TWI343257B (en) 2011-06-11
NO333744B1 (no) 2013-09-09
KR20060118422A (ko) 2006-11-23
US20090306113A1 (en) 2009-12-10
RU2359660C2 (ru) 2009-06-27
IL173910A0 (en) 2006-07-05
MXPA06002436A (es) 2006-06-20
EP1663243B1 (en) 2009-02-18
CN1874778A (zh) 2006-12-06
GB0320522D0 (en) 2003-10-01
PT1663243E (pt) 2009-04-27
HK1091734A1 (en) 2007-01-26
JP4892346B2 (ja) 2012-03-07
AU2004268376A1 (en) 2005-03-10
WO2005021002A1 (en) 2005-03-10
CN102204891B (zh) 2013-08-21
AU2004268376B2 (en) 2010-04-22
CY1108953T1 (el) 2014-07-02
IL173910A (en) 2010-11-30
JP2007504195A (ja) 2007-03-01
DE602004019547D1 (de) 2009-04-02
KR101115984B1 (ko) 2012-03-13
NO20061514L (no) 2006-04-03
ES2319124T3 (es) 2009-05-04
US8772303B2 (en) 2014-07-08
MA28033A1 (fr) 2006-07-03
MY139165A (en) 2009-08-28
NZ545453A (en) 2009-12-24
IS2677B (is) 2010-09-15

Similar Documents

Publication Publication Date Title
PT1289955E (pt) Piperidinas para utilizacao como antagonistas dos receptores da orexina
WO2002089800A3 (en) N-aroyl cyclic amine derivatives as orexin receptor antagonists
DE60226875D1 (de) Orthosubstituierte arylamide zur bekämpfung von wirbellosen schädlingen
CO5280046A1 (es) Agonistas alfa 7 y sus composiciones farmaceuticas
HUP0004333A2 (hu) Új triazolo [4,5-d] pirimidin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP9901820A2 (hu) 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
ES2161382T3 (es) Derivados de pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
GB0128499D0 (en) Therapeutic agents
AR007077A1 (es) Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento
YU48714B (sh) Derivati benzofurana, benzotiofena, indola i indolizina i postupak za njihovo dobijanje
AR039127A1 (es) Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento
ES2121441T3 (es) Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco
HRP20040429B1 (hr) Derivati sulfonamida, njihova priprema i upotrebakao lijekova
WO2008087611A3 (en) Pyrrolidine- and piperidine- bis-amide derivatives
AP2001002114A0 (en) Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents).
HUP9901613A2 (hu) Szubsztituált tetraciklusos kondenzált furán-amin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
TW200738620A (en) Fluoroalkenyl derivatives as insecticides and nematicides
DE60320012D1 (de) Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen
HUP0402261A2 (hu) Piperidinszármazékok és alkalmazásuk kemokin receptor aktivitás modulátoraiként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DK173783D0 (da) Fremgangsmade til fremstilling af imidazo (1,2-alfa)pyridiner
TW200510320A (en) Aminoquinoline derivatives and their use as adenosine A3 ligands
HRP20030610B1 (en) Process for the preparation of mesylates of piperazine derivatives
NO20081068L (no) Kinolinderivater som antibakterielle midler
WO2001045637A3 (en) Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides
DE69934514D1 (de) Chinolinderivate als nk-2 und nk-3 rezeptor-liganden